News

Integrated care and value health set to soar in Europe

European politicians increasingly get the value of care which integrates social and acute or the holistic treatment of chronic diseases. They also want value healthcare models which reward operators for quality. Pilots are becoming larger and, in some cases, have been rolled out as long-term projects covering millions of people. There are plenty of opportunities for nimble private sector players. We look at what is happening across Europe. [+]

Insight & Interviews

Interview: Ameos CEO says it is not for sale and discusses his business strategy

None of the major shareholders in German’s largest psychiatry player Ameos will sell this year as the group relies on organic growth over privatisations to drive sales beyond €850m, says CEO Dr Axel Paeger. [+]

Reports

Real solutions for retention and recruitment

Recruitment, retention and training are now the primary challenges for the healthcare services industry. The obvious solution to keeping staff - paying more – is no longer working. Private operators around the world are now fishing in a global market that's short of 15m healthcare workers. So what practical solutions are operators putting into force and what really works? We talk to 25 operators from across the world. [+]
See All Healthcare Europa >

News

New medical services for Africa

An African temporary medical staff agency, international telepathology for diagnosing cancer and a cloud-based HR service are among the new projects from Corvus Health, the new for-profit business launched by Katherine Tulenko, an American with 15 years experience in health care services in emerging markets. She is a speaker at HBI 2018, April 10-11, 2018 in London. We explore the projects. [+]

Insight & Interviews

Interview: Shamsheer Vayalil, CEO, VPS Healthcare

VPS Healthcare, the GCC/Indian hospital and generic drugs group, with 2017 sales of about $1bn, plans to IPO within 2-3 years. Meanwhile, it wants to invest $150m in Indian hospitals. VPS founder 40 year-old Dr Shamsheer Vayalil, has also just launched a private equity fund Trovant Capital which has made its first investment buying a hunk of Amanat, a GCC fund which is investing (rather slowly) in healthcare and education. We caught up with him in London. [+]

Reports

Where is the genetics industry headed?

The company to offer the first thousand dollar genome claims it will soon have a monopoly in genetics to rival that of Amazon in retail. In doing so, could Veritas Genetics finally deliver on the false promises of the industry and revolutionise healthcare as a whole?  [+]
See All Healthcare Nova >